Published in Circulation on May 01, 1993
Techniques to avoid atrioventricular block during radiofrequency catheter ablation of septal tachycardia substrates in young patients. J Interv Card Electrophysiol (2002) 1.07
Effect of sequential radiofrequency ablation lesions at fast and slow atrioventricular nodal pathway positions in patients with paroxysmal atrial fibrillation. Heart (1996) 0.94
Recognition of inferiorly dislocated fast pathways guided by three-dimensional electro-anatomical mapping. J Interv Card Electrophysiol (2011) 0.90
Long term results of fast pathway ablation in atrioventricular nodal reentry tachycardia using a modified technique. Br Heart J (1995) 0.82
Intracardiac echocardiography guided radiofrequency catheter ablation of the slow pathway in atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol (2002) 0.80
Radiofrequency Catheter Ablation of Atrioventricular Nodal Reentrant Tachycardia: Success Rates and Complications during 14 Years of Experience. J Tehran Heart Cent (2010) 0.80
Fast or slow pathway ablation (or neither) for AV nodal tachycardia? Heart (1997) 0.75
Cryoablation Versus Radiofrequency Ablation in AVNRT: Same Goal, Different Strategy. J Atr Fibrillation (2015) 0.75
Radiofrequency catheter ablation: a new frontier in interventional cardiology. Br Heart J (1994) 0.75
Change in delay of atrioventricular conduction after radiofrequency catheter ablation for atrioventricular nodal re-entry tachycardia. Br Heart J (1995) 0.75
Jean Nicolas Corvisart (1755-1821). Heart (1997) 0.75
Atrioventricular node reentrant tachycardia in patients with a prolonged AH interval during sinus rhythm: clinical features, electrophysiologic characteristics and results of radiofrequency ablation. J Interv Card Electrophysiol (1997) 0.75
The electrophysiologic characteristics in patients with only ventricular-pacing inducible slow-fast form atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol (2006) 0.75
The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA (1995) 3.93
Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med (1997) 3.85
Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med (1990) 3.29
Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet (1995) 3.02
Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol (2000) 2.67
Clinical consequences of electrocardiographic artifact mimicking ventricular tachycardia. N Engl J Med (1999) 2.66
A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation (1992) 2.62
Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation (1997) 2.53
Physician interpretation of electrocardiographic artifact that mimics ventricular tachycardia. Am J Med (2001) 2.47
Differentiation of atypical atrioventricular node re-entrant tachycardia from orthodromic reciprocating tachycardia using a septal accessory pathway by the response to ventricular pacing. J Am Coll Cardiol (2001) 2.40
Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA (2001) 2.38
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A (1995) 2.33
Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med (1991) 2.32
Temperature monitoring during radiofrequency catheter ablation of accessory pathways. Circulation (1992) 2.31
Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation (1993) 2.28
Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol (1998) 2.25
Placement of electrode catheters into the coronary sinus during electrophysiology procedures using a femoral vein approach. Am J Cardiol (1994) 2.19
A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J Am Coll Cardiol (1999) 2.13
Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med (1999) 2.12
Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA (1982) 2.08
Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation (1992) 2.00
Visualization and temporal/spatial characterization of cardiac radiofrequency ablation lesions using magnetic resonance imaging. Circulation (2000) 1.96
Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med (1994) 1.94
Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections. Circulation (1992) 1.88
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A (1996) 1.84
Analysis of the pattern of initiation of sustained ventricular arrhythmias in patients with implantable defibrillators. J Cardiovasc Electrophysiol (2000) 1.73
Long-term results of catheter ablation of idiopathic right ventricular tachycardia. Circulation (1990) 1.73
Coexistent Mahaim and Kent accessory connections: diagnostic and therapeutic implications. J Am Coll Cardiol (1987) 1.72
A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator. Circulation (1997) 1.71
Nonpharmacological approaches to atrial fibrillation. Circulation (2001) 1.70
Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci (1996) 1.70
Is ilioinguinal/iliohypogastric nerve block always totally safe in children? Paediatr Anaesth (2003) 1.66
Electrogram polarity and cavotricuspid isthmus block during ablation of typical atrial flutter. J Cardiovasc Electrophysiol (2001) 1.65
Radiation exposure during radiofrequency catheter ablation of accessory atrioventricular connections. Circulation (1991) 1.62
Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol (1996) 1.62
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol (1996) 1.61
Effect of chronic amiodarone therapy on defibrillation energy requirements in humans. J Cardiovasc Electrophysiol (2000) 1.59
A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. Circulation (1991) 1.58
Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations. Circulation (2000) 1.58
Interference from a hand held radiofrequency remote control causing discharge of an implantable defibrillator. Pacing Clin Electrophysiol (1993) 1.57
Ventricular pacing with premature excitation for treatment of hypertensive-cardiac hypertrophy with cavity-obliteration. Circulation (1999) 1.56
Biventricular pacing using two pacemakers and the triggered VVT mode. Pacing Clin Electrophysiol (2001) 1.55
Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol (1998) 1.53
Relationship between serum potassium concentration and risk of recurrent ventricular tachycardia or ventricular fibrillation. J Cardiovasc Electrophysiol (2001) 1.51
Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation. J Cardiovasc Electrophysiol (1999) 1.50
2:1 atrioventricular block during atrioventricular node reentrant tachycardia. J Am Coll Cardiol (1996) 1.48
Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol (1999) 1.45
Effects of simultaneous atrioventricular pacing on atrial refractoriness and atrial fibrillation inducibility: role of atrial mechanoelectrical feedback. J Cardiovasc Electrophysiol (2001) 1.44
Electrocardiographic differentiation of atrial flutter from atrial fibrillation by physicians. J Electrocardiol (1999) 1.44
In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res (2000) 1.43
Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone. J Am Coll Cardiol (1992) 1.42
Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two, and three extrastimuli. Circulation (1994) 1.41
Seasonal and mood independence of low basal prolactin secretion in premenopausal women with seasonal affective disorder. Am J Psychiatry (1989) 1.40
Disopyramide. Ann Intern Med (1982) 1.38
[Patients with panic disorder: a 5-year follow-up study]. Acta Psiquiatr Psicol Am Lat (1992) 1.37
Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth (2006) 1.33
The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J (2000) 1.33
Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry (1996) 1.33
A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions (1993) 1.32
Intracardiac echocardiography to guide transseptal left heart catheterization for radiofrequency catheter ablation. J Cardiovasc Electrophysiol (1999) 1.31
Adenosine-induced atrial arrhythmia: a prospective analysis. Ann Intern Med (1997) 1.30
Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation (1997) 1.30
Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia. Am J Cardiol (1983) 1.29
Double potentials along the ablation line as a guide to radiofrequency ablation of typical atrial flutter. J Am Coll Cardiol (2001) 1.25
Pharmacological effects of phosphatidylserine liposomes. Nature (1976) 1.22
Safety and effectiveness of placement of pacemaker and defibrillator leads in the axillary vein guided by contrast venography. Am J Cardiol (1997) 1.20
An integrated restriction fragment length polymorphism--amplified fragment length polymorphism linkage map for cultivated sunflower. Genome (2001) 1.19
Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol (1991) 1.19
Voltage-dependent activation and inactivation of calcium channels in PC12 cells. Correlation with neurotransmitter release. J Biol Chem (1987) 1.19
Nerve growth factor activates Thy-1 and neurofilament gene transcription in rat PC12 cells. EMBO J (1986) 1.19
Recurrence of conduction in accessory atrioventricular connections after initially successful radiofrequency catheter ablation. J Am Coll Cardiol (1992) 1.19
Randomized, double-blind trial of simultaneous right and left atrial epicardial pacing for prevention of post-open heart surgery atrial fibrillation. Circulation (2000) 1.18
Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J Pers Soc Psychol (1994) 1.18
Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol (2000) 1.17
Direct interaction of proliferating cell nuclear antigen with the p125 catalytic subunit of mammalian DNA polymerase delta. J Biol Chem (1999) 1.17
Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest (1973) 1.16
Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett (1982) 1.16
Catheter ablation of atrial flutter using radiofrequency energy. Am J Cardiol (1994) 1.16
Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J (1991) 1.15